Population-based cancer survival (2001 to 2009) in the United States: Findings from the CONCORD-2 study

Cancer

Volumn 123, Issue , 2017, Pages 4963-4968

  Weir, Hannah K ^a   Stewart, Sherri L ^a   Allemani, Claudia ^b   White, Mary C ^a   Thomas, Cheryll C ^a   White, Arica ^a   Coleman, Michel P ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; CANCER SURVIVOR; CAUSE OF DEATH; COLON CANCER; CONTROLLED STUDY; DEMOGRAPHY; EARLY DIAGNOSIS; EDITORIAL; FEMALE; HUMAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; STOMACH CANCER; UNITED STATES; UTERINE CERVIX CANCER; MORTALITY; NEOPLASM; REGISTER; STATISTICS AND NUMERICAL DATA;

CANCER SURVIVORS; HUMANS; NEOPLASMS; REGISTRIES; UNITED STATES;

EID: 85037657444     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31028     Document Type: Editorial

References (45)

1. Jim MA, Pinheiro PS, Carreira H, Espey DK, Wiggins CL, Weir HK. Stomach cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:4994-5013.
2. Joseph DA, Johnson CJ, White A, Wu M, Coleman MP. Rectal cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5037-5058.
3. White A, Joseph DA, Rim SH, Johnson CJ, Coleman MP, Allemani C. Colon cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5014-5036.
4. Momin BR, Pinheiro PS, Carreira H, Li C, Weir HK. Liver cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5059-5078.
5. Richards TB, Henley SJ, Puckett MC, et al. Lung cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5079-5099.
6. Miller JW, Lee Smith J, Ryerson AB, Tucker TC, Allemani C. Disparities in breast cancer survival in the United States (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5100-5118.
7. Benard V, Watson M, Saraiya M, et al. Cervical cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5119-5137.
8. Stewart SL, Harewood R, Matz M, et al. Disparities in ovarian cancer survival in the United States (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5138-5159.
9. Steele CB, Li J, Huang B, Weir HK. Prostate cancer survival in the United States by race and stage (2001-2009): findings from the CONCORD-2 study. Cancer. 2017;123:5160-5177.
10. Tai E, Ward KC, Bonaventure A, Siegel D, Coleman MP. Survival among children diagnosed with acute lymphoblastic leukemia in the United States by race and age, 2001-2009: findings from the CONCORD-2 study. Cancer. 2017;123:5178-5189.
11. Allemani C, Weir HK, Carreira H, et al; CONCORD Working Group. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385:977-1010.
12. White MC, Babcock F, Hayes NS, et al. The history and use of cancer registry data by public health cancer control programs in the United States. Cancer. 2017;123:4969-4976.
13. Cho H, Mariotto AB, Schwartz LM, Luo J, Woloshin S. When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr. 2014;49:218-27.
14. Weir HK, Anderson RN, Coleman King SM, et al. Heart disease and cancer deaths-trends and projections in the United States, 1969-2020. Prev Chronic Dis. 2016;13:E157.
15. Weir HK, Thompson TD, Soman A, Moller B, Leadbetter S, White MC. Meeting the Healthy People 2020 objectives to reduce cancer mortality. Prev Chronic Dis. 2015;12:E104.
16. Weir HK, Thompson TD, Soman A, Moller B, Leadbetter S. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer. 2015;121:1827-1837.
17. de Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22:561-570.
18. White MC, Hayes NS, Richardson LC. Public health's future role in cancer survivorship. Am J Prev Med. 2015;49(6 suppl 5):S550-S553.
19. Colditz GA, Wolin KY, Gehlert S. Applying what we know to accelerate cancer prevention. Sci Transl Med. 2012;4:127rv4.
20. Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011;10:2006-2014.
21. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103:117-128.
22. Buchanan ND, Houston K, Richardson LC. The essential role of public health in preventing disease, prolonging life, and promoting health of cancer survivors. Am J Prev Med. 2015;49(6 suppl 5):S467-S469.
23. Buchanan ND, Dasari S, Rodriguez JL, et al. Post-treatment neurocognition and psychosocial care among breast cancer survivors. Am J Prev Med. 2015;49(6 suppl 5):S498-S508.
24. Coates RJ, Stanbury M, Jajosky R, et al. Introduction to the Summary of Notifiable Noninfectious Conditions and Disease Outbreaks - United States. MMWR Morb Mortal Wkly Rep. 2016;63:1–4.
25. Coleman MP. Cancer survival: global surveillance will stimulate health policy and improve equity. Lancet. 2014;383:564-573.
26. Allemani C, Coleman MP. Public health surveillance of cancer survival in the US and worldwide: the contribution of the CONCORD programme. Cancer. 2017;123:4977-4981.
27. Karanikolos M, Ellis L, Coleman MP, McKee M. Health systems performance and cancer outcomes. J Natl Cancer Inst Monogr. 2013;2013:7-12.
28. Coleman MP, Quaresma M, Berrino F, et al; CONCORD Working Group. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730-756.
29. Allemani C, Harewood R, Johnson CJ, et al. Population-based cancer survival in the US: data, quality control, and statistical methods. Cancer. 2017;123:4982-4993.
30. Jemal A, Ward EM, Johnson CJ, et al. Annual Report to the Nation on the Status of Cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109(9).
31. Smith RA, von Eschenbach AC, Wender R, et al; ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin. 2001;51:38-75.
32. Rachet B, Ellis L, Maringe C, et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer. 2010;103:446-453.
33. Walters S, Benitez-Majano S, Muller P, et al. Is England closing the international gap in cancer survival? Br J Cancer. 2015;113:848-860.
34. Puckett MC, Townsend JS, Gelb CA, Hager P, Conlon A, Stewart SL. Ovarian cancer knowledge in women and providers following education with Inside Knowledge campaign materials [published online ahead of print June 24, 2017]. J Cancer Educ. doi: 10.1007/s13187-017-1245-0.
35. Brawley OW. Is race really a negative prognostic factor for cancer? J Natl Cancer Inst. 2009;101:970-971.
36. Brawley OW. Lung cancer and race: equal treatment yields equal outcome among equal patients, but there is no equal treatment. J Clin Oncol. 2006;24:332-333.
37. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287:2106-2113.
38. Weir HK, Li C, Henley SJ, Joseph D. Years of Life and Productivity Loss from Potentially Avoidable Colorectal Cancer Deaths in U.S. Counties with Lower Educational Attainment (2008-2012). Cancer Epidemiol Biomarkers Prev. 2017;26:736–742.
39. Butler J, Foot C, Bomb M, et al; ICBP Working Group. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom. Health Policy. 2013;112:148-155.
40. Weller D, Vedsted P, Anandan C, et al; ICBP Module 4 Working Group. An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation. BMJ Open. 2016;6:e009641.
41. Brown S, Castelli M, Hunter DJ, et al. How might healthcare systems influence speed of cancer diagnosis: a narrative review. Soc Sci Med. 2014;116:56-63.
42. Rose PW, Rubin G, Perera-Salazar R, et al; ICBP Module 3 Working Group. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey. BMJ Open. 2015;5:e007212.
43. Weir HK, Johnson CJ, Mariotto AB, et al. Evaluation of North American Association of Central Cancer Registries' (NAACCR) data for use in population-based cancer survival studies. J Natl Cancer Inst Monogr. 2014;2014:198-209.
44. Pinheiro PS, Morris CR, Liu L, Bungum TJ, Altekruse SF. The impact of follow-up type and missed deaths on population-based cancer survival studies for Hispanics and Asians. J Natl Cancer Inst Monogr. 2014;2014:210-217.
45. Johnson CJ, Weir HK, Fink AK, et al; Accuracy of Cancer Mortality Study Group. The impact of National Death Index linkages on population-based cancer survival rates in the United States. Cancer Epidemiol. 2013;37:20-28.